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The genome of the nematode Caenorhabditis elegans is unusual among eukaryotes, in that it contains operons. Approximately 15% of genes
in the worm are clustered into groups of between two and eight genes, which are under the control of shared regulatory sequences. Polycistronic
transcripts from such operons are trans-spliced, during transcription, to produce mature monocistronic messengers. The C. elegans frataxin gene,
frh-1, is encoded in the operon CEOP2232. This is one of the largest operons identified thus far in the C. elegans genome. Here we describe in
detail the structure of all of the coding units within this operon. The operon is composed of eight genes of a diverse nature, organized in a complex
structure. We have produced transgenic strains carrying fusions between gfp and a number of genes from the operon. These constructs show
complex differential expression patterns that suggest the presence of internal promoters and regulatory sequences in the operon. This organization
would permit both coordinated expression and differential expression of the components of the CEOP2232 operon. The heterogeneity of the
genes, and their complex expression patterns, suggests that the clustering of CEOP2232 is not due to a need for synchronized expression of genes
involved in the same physiological pathway.
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Some genes of the nematode Caenorhabditis elegans
possess the extraordinary characteristic of being organized as
polycistronic units or eukaryotic operons [1–3]. As in bacterial
operons, these sets of genes share a common promoter and
regulatory sequences that allow coordinated expression of the
encoded proteins. In contrast with prokaryotic operons, C.
elegans polycistronic transcripts are processed as they arise,
producing mature monocistronic messengers that can then be
transported to the cytoplasm and translated. This process
involves another unusual feature of C. elegans gene expression,
trans-splicing [4]. Approximately 70% of C. elegans genes are
trans-spliced [5]. Trans-splicing uses a mechanism similar to⁎ Corresponding author.
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doi:10.1016/j.ygeno.2006.10.007that of cis-splicing but utilizes two sequences expressed from
different loci, the spliced leader RNA (SL RNA) and the mRNA
itself [4,6]. The pre-SL RNA donates the 22-nucleotide spliced
leader (SL), which has a trimethyl G cap at its 5′ end that
stabilizes the messenger and facilitates translation [7,8]. Trans-
spliced leaders are spliced onto mRNAs containing an outron,
an intron-like sequence that has only a 3′ acceptor site. There
are two major types of trans-splicing in C. elegans: (1) trans-
splicing of the spliced leader SL1 to standard mRNAs that
contain an outron [4]; (2) trans-splicing of the spliced leader
SL2 to mRNAs derived from polycistronic transcripts in which
the outron is preceded by another coding sequence with a
polyadenylation signal [5]. Consequently, SL1-mediated trans-
splicing processes both single coding units and genes located
immediately downstream of a promoter in an operon, whereas
SL2-mediated trans-splicing processes downstream genes in
operons [9,10]. In operons, the polyadenylation site of the
Table 1
Trans-splicing sites for the genes of the operon CEOP2232
Gene RT-PCRa ESTb Intergenic
distance c
SL1 SL2 SL1 SL2
F59G1.4 + − 0 0 415
tsp-18 + + 0 0 261
F59G1.8 + + 0 0 202
vps-35 + + 3 0 105
ctg-3 (F59G1.1b.1) − + 1 13 511
ctg-3 (F59G1.1b.2) + + 39 1
ctg-3 (F59G1.1b.3) + − 2 0
frh-1 + + 0 2 328
ptp-2 + + 1 0 345
vrk-1 (F28B12.3.1) − − 1 2 >8 kb d
vrk-1 (F28B12.3.2) + + 0 1
a Presence (+) or absence (−) of SL1 or SL2 trans-spliced measured by RT-
PCR (this work).
b Number of ESTs carrying SL1 or SL2 sequences shown in WormBase
(www.wormbase.org release WS157).
c Distance between the polyadenylation site of a gene and the trans-splicing
site of the downstream gene.
d Distance to the next predicted downstream gene (www.wormbase.org).
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gene are usually separated by between 30 and 360 bp, although
in some cases the distance may be up to 1 or 2 kb [11]. SL2-
mediated trans-splicing and polyadenylation of the upstream
messenger are coupled [10,12]. Mutations in the polyadenyla-
tion site of the upstream gene reduce the efficiency of trans-
splicing of the downstream gene, demonstrating that successful
polyadenylation of a gene facilitates efficient SL2 trans-splicing
of the downstream gene. This suggests that the efficiency with
which a gene in an operon is processed will influence the
expression of a downstream gene.
C. elegans operons contains an average of 2.6 genes, with 8
genes in the largest operon described thus far [9]. The
orthologues of several genes involved in human disease are
contained in operons [9]. This is the case for the C. elegans
frataxin gene, frh-1, which is located within an unusually large
operon, CEOP2232, which was predicted to contain 7 genes [9].
frh-1 is the C. elegans homologue of FXN, deficiency of which
causes Friedreich’s ataxia in humans [13,14]. Human frataxin is
a mitochondrial protein. The function of frataxin remains poorly
understood, although several hypotheses have been proposed
[15]. FXN is highly expressed in the heart and nervous system
and in other tissues with a high energy requirement. Consistent
with this expression pattern, its deficiency causes cardiomyo-
pathy and neurodegeneration in patients. We have established a
C. elegans model to study the function of frataxin and to test
possible therapeutic treatments for Friedreich’s ataxia [16]. An
important part of this work is to determine when and where
frataxin is expressed in C. elegans, thus allowing us to compare
its expression with human frataxin. As frh-1 is located within a
large operon, it is therefore important to investigate the structure
and regulation of this set of genes, as their expression may be
relevant to the expression and function of the frataxin gene.
In this work, we present the first detailed description of a
large operon in C. elegans. We have cloned and analyzed the
mRNAs of all the genes in the CEOP2232 operon. We have
shown that it is composed of eight rather than seven genes. We
investigated the expression of the genes using transgenic strains
carrying fusions of the reporter gene gfp (green fluorescent
protein) to several genomic regions of the operon. These
experiments revealed a complex picture in which frataxin is
expressed in different tissues than other genes of the operon.
Based on the results of these experiments, we propose the
existence of multiple internal promoters and regulatory
sequences within the frataxin-encoding operon.
Results and discussion
Structure of the operon CEOP2232
The C. elegans frataxin gene, frh-1 [16], is contained within
the operon CEOP2232 [9]. To characterize the expression of the
frataxin gene, it was first necessary to understand, in detail, the
structure of the CEOP2232 operon. When we started this work,
there was little EST data for the genes in the operon. We there-
fore wished to determine, for each gene, its exact trans-splicing
and polyadenylation sites together with its mRNA structure.To determine trans-splicing sites, we performed RT-PCR
using the sequences of the spliced leaders SL1 and SL2 as
forward primers together with gene-specific reverse primers
(Supplementary Table S1). This enabled us to determine the
exact trans-splicing site(s) for each gene (Supplementary Table
S2). Initially, we tested the most upstream gene in the predicted
operon, tsp-18. We found that tsp-18 was trans-spliced to both
SL1 and SL2 (Table 1). The presence of SL2-spliced message
(generally associated with internal genes within operons)
suggested that tsp-18 was not the first gene in the operon.
The two genes upstream of tsp-18 are lin-4 and F59G1.4. lin-4,
a miRNA [17], is not trans-spliced and so it is unlikely to be part
of the operon. The predicted structure of F59G1.4 placed its 3′
end 5 kb away from tsp-18 (Fig. 1); however, by 3′-RACE we
showed that the actual 3′ end of F59G1.4 is in fact just 415 bp
from the 5′ end of tsp-18 (Table 1). The new predicted exons
show a high level of similarity to the corresponding sequence of
the genome of C. briggsae (Fig. 1). lin-4 is thus now located in
an intron of F59G1.4 (Fig. 1), a common feature of miRNA
genes [18]. F59G1.4 is expressed only with the SL1-spliced
leader (Table 1), suggesting that this is the gene leader in the
CEOP2232 operon. Thus, the operon contains at least eight
genes, making it one of the two largest operons described, thus
far, in C. elegans.
We next performed similar experiments on the remaining six
genes of the operon and determined their exact trans-splicing
sites (Supplementary Table S2). To determine the polyadenyla-
tion sites for each mRNA, we performed 3′-RACE and cloned
and sequenced the resulting PCR products (Supplementary
Table S3). The distances between the polyadenylation and
trans-splicing sites in the CEOP2232 operon range from 105 to
511 bp (Table 1), i.e., within the normal range of distances in
C. elegans operons [11]. Finally, we amplified the sequence
between the two mRNA ends of each gene and cloned and
sequenced the resulting products to predict the structure of
394 R.P. Vázquez-Manrique et al. / Genomics 89 (2007) 392–401each gene. The proposed full structure of the operon derived
from our results is shown in Fig. 2.
Downstream mRNAs are trans-spliced to both SL1 and SL2
Our analysis of the structure of CEOP2232 revealed that,
with the exception of the gene leader F59G1.4, all of the genes
in the operon were trans-spliced to both SL1 and SL2 (Table 1).
However, the proportions of each mRNA that were trans-
spliced to each spliced leader varied. In the case of tsp-18, the
band of the SL1 product was stronger than that of SL2,
suggesting preferential trans-splicing with that sequence. In
contrast, F59G1.8 produced a more intense band for the SL2
product (data not shown) and vps-35 appeared to be equally
expressed with SL1 and SL2. Analysis of the next gene in the
operon, cgt-3, revealed a complex structure. When using the
SL1 primer, we obtained products of several different sizes.
When we cloned and sequenced these products, it became
apparent that cgt-3 has several alternative 5′ ends (Supplemen-
tary Table S2; Fig. 3). This is in agreement with the different
predicted messengers described in WormBase for this gene. The
relative strength of the SL1 and SL2 bands depends on the
particular splice variant and is discussed in more detail below.
For the frataxin gene, frh-1, we obtained more product when
using SL2, indicating that the expression of this gene is
predominantly with this sequence. Finally, both ptp-2 and vrk-1
showed equal and strong amplification with SL1 and SL2.
The operon CEOP2232 contains internal promoters
Several authors have proposed that C. elegans operons may
contain internal promoters [19,20]. We have shown previously
that the frataxin gene can be expressed from transgenes that do
not contain the entire operon [16]. To do this, we produced
constructs containing genomic regions, of a range of sizes,
containing frh-1 fused (in-frame) to the gfp gene, which we
named frh-1::gfp1, frh-1::gfp2, and frh-1::gfp3 (Fig. 2b). Their
expression patterns are detailed in Table 2. In summary, the
three constructs showed different but specific and reproducibleFig. 1. Structure of the 5′ region of the CEOP2232 operon, showing genes F59G1.4 a
and orientation of the predicted genes F59G1.4, lin-4, and tsp-18. Exons are represen
blue, light blue, and gray bars represent high, low, and no similarity, respectively. (b)
mRNA. Note that the C. briggsae sequence shows a high level of similarity in the rexpression patterns, strongly suggesting that the region around
frh-1 contains several regulatory sequences. Importantly, these
regulatory sequences promote the expression of the frataxin
gene independently of the expression of the upstream genes,
suggesting that frataxin expression is driven by internal
promoters within CEOP2232.
To test for the presence of other internal promoters in the
operon, we performed similar experiments on some of the other
genes. First, we produced a construct of the 5′ region of the cgt-
3 gene, cgt-3::gfp. This gene has three alternative 5′ ends
separated by relatively long noncoding sequences, which
contain regions with a high level of similarity to the correspond-
ing sequence from C. briggsae (data not shown). This structure
suggests that these intronic regions may contain regulatory
elements. The genomic region in the cgt-3::gfp construct
overlaps substantially with constructs frh-1::gfp1 and 3 (Fig.
2b and Supplementary Fig. S1). Interestingly, this construct
produced an expression pattern very similar to that of frh-1::
gfp1 and 3, showing expression in the gut, pharynx, sperma-
theca, and anal cells (Table 2 and Figs. 4a–4c), indicating that
the sequences that drive frh-1 and cgt-3 expression in these
tissues are probably located in the cgt-3 region (Supplementary
Fig. S1). Moreover, there are several binding sites for GATA-
like transcription factors in the overlapping region between cgt-
3::gfp, frh-1::gfp1, and 3 (data not shown) [21]. However, in
contrast to frh-1::gfp1 and 2, cgt-3::gfp did not show expression
in head neurons, suggesting that regulatory sequences required
for frh-1 expression in the nervous system are located in a region
close to or within the frataxin gene (Supplementary Fig. S1).
We next produced gfp fusion constructs for the ptp-2 and
vrk-1 genes (ptp-2::gfp and vrk-1::gfp) (Fig. 2b and Supple-
mentary Fig. S1), both of which produced consistent expression
patterns (Table 2 and Figs. 4d–4h). ptp-2::gfp produced a
complex expression pattern, which is different from that seen
with frh-1::gfp, again indicating that the regulatory sequences
that drive ptp-2 expression are located close to the gene. Inte-
restingly, Gutch and co-workers were able to rescue the phe-
notype of the ptp-2(op194) mutant, using the cosmid F28F12
[22], which contains only a part of CEOP2232, including ptp-2nd tsp-18. (a) Diagram of the region taken fromWormBase showing the position
ted in pink. Homology to the C. briggsae genome is shown at the bottom. Dark
Revised gene models and genomic arrangement, based on the analysis of cloned
egion corresponding to the last three exons of the proposed F59G1.4 gene.
Fig. 2. The genomic structure of the CEOP2232 operon and gfp fusion constructs. (a) Colored boxes indicate sequences present in the mature mRNA (i.e., exons and
UTRs). Each gene is distinguished by a different color. The sequenced region of the insert in cosmids that cover the region are shown at the top. (b) Diagram of
constructs obtained either by fusion PCR (this work) or by cloning DNA fragments (marked with an asterisk) [15]. The putative homologous recombination event
between frh-1::gfp2 and the cosmid F59G1 is shown at the bottom. The location of gfp is indicated by a blue triangle.
395R.P. Vázquez-Manrique et al. / Genomics 89 (2007) 392–401itself and a small region upstream. This means that sequences
directly upstream of ptp-2 are sufficient to drive its expression
in the appropriate tissues, again indicating the existence of an
internal promoter.
F59G1.4 and frh-1 are expressed differentially
The results presented above show that frh-1 is expressed
from internal promoters. However, we hypothesized that as theFig. 3. Structure of the 5′ region of the F59G1.1 gene (cgt-3) showing trans-splicin
spliced leaders with which they are processed are shown at the bottom. Note that onl
with SL2. The asterisk indicates that the presence of SL1 in this variant is rare (seefrataxin gene is part of an operon, we may also expect its
expression to be co-regulated by sequences upstream of the 5′-
most gene in the operon, F59G1.4. Hence, frh-1 and F59G1.4
should share similarities in their expression patterns. To
investigate this question, we made a construct that included
the whole region of the operon upstream of frh-1 and in which
frh-1 was translationally fused to gfp. To achieve this, we took
advantage of the ability to use naturally occurring homologous
recombination to reconstruct genes in C. elegans [23–25]. Weg sites. Diagrammatic representations of the splicing variants together with the
y the two exons closest to vps-35 (106 and 1338 bp, respectively) are processed
Table 1).
Table 2
Expression patterns of gfp fusion constructs for genes in CEOP2232
Construct Genome sequence a 5′ gene codons
fused to gfp
Site of expression
F59G1.4::gfp −3102–1642 1–209 Head neurons: inner labial neurons, amphids, phasmids
vps-35::gfp −3102–12896 1–328 Head neurons: inner labial neurons, amphids, phasmids
cgt-3::gfp 15411–19054 1–55 Pharynx, spermatheca, gut, anal cells
frh-1::gfp1 b 15965–24000 1–135 Amphid and other head neurons, pharynx, gut, spermatheca
frh-1::gfp3 b 9090–21347 1–8 Pharynx, gut, spermatheca, muscle cells, anal cells
frh-1::gfp2 b 20654–22220 1–135 Amphid and other head neurons
frh-1::gfp2+F59G1 b −3102–22220 c 1–135 Amphid and other head neurons, pharynx, gut, spermatheca,
muscle cells, anal cells
ptp-2::gfp 22021–22637 1–8 Head neurons, spermatheca, gut, body wall muscles
vrk-1::gfp 24694–4459 d 1–8 Head neurons, spermatheca, gut, pharynx, vulva, phasmids
a Nucleotide number within the F59G1 cosmid (Accession No. U53332). Under Genome sequence, −3102 indicates the 5′ nucleotides upstream of the first gene in
the operon, F59G1.4.
b Described in [15].
c Construct obtained by homologous recombination.
d Nucleotide number at 3′ corresponds to position in cosmid F28B12 (Accession No. U29537).
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derived from an equimolar mixture of the construct frh-1::gfp2
and the cosmid F59G1. F59G1 contains most of the operon and
some upstream DNA [16] (Fig. 2b). frh-1::gfp2 expresses gfp
only in a few head neurons (Table 2). In contrast, the transgenic
lines carrying arrays made of frh-1::gfp2 and the F59G1 cosmid
mimic the expression pattern produced by the constructs frh-1::
gfp1 and frh-1::gfp3. This suggests that homologous recombi-
nation fused both molecules, thus assembling the operon from
upstream of its start site down to frh-1 fused to gfp. We can
assume that this is a good representation of the real expression
pattern of the frataxin gene. These strains showed expression of
gfp in several tissues: muscles, gut, pharynx, spermatheca, and
head neurons. To compare this expression pattern with that
resulting from the putative promoter at the start site of the
operon, we produced two gfp fusion constructs. The first
contained the 5′ upstream region of the operon fused to gfp, in-
frame with the eighth exon of F59G1.4, the operon gene leader
(Fig. 2b and Supplementary Fig. S1). Animals carrying this
construct show a different expression pattern from that of frh-1.
The pattern was predominantly neuronal (Fig. 5a, and Table 2)
and, in contrast with frh-1 expression, was not observed in the
gut, pharynx, or spermatheca. The nature of the neuronal ex-
pression was also different, as frh-1 is expressed in the amphid
cells and other neurons around the posterior part of the pharynx
(Fig. 5a and Table 2), whereas F59G1.4 was expressed in
amphid and labial neurons (Fig. 5b and Table 2) and posterior
phasmid neurons. The second construct contained the 5′ up-
stream region of the operon to the fourth exon of the second gene
in the operon, vps-35, again fused to gfp (Fig. 2b and Supple-
mentary Fig. S1). The expression of this construct matched the
expression of the F59G1.4 gene (Table 2), suggesting that the
expression of both genes is under the control of the same
regulatory elements. Hence, the genes situated at the 5′ region of
the operon (at least F59G1.4 and vps-35) are expressed in dif-
ferent cells than frh-1, suggesting that the promoter located
upstream of F59G1.4 does not play a substantial role in regula-
ting the expression of some of the genes within the operon.The presence of internal promoters in the operon CEOP2232
may contribute to the trans-splicing of SL1 to downstream
genes
As mentioned previously, most of the transcripts in
CEOP2232 are spliced to both SL1 and SL2. The presence of
internal promoters in the operon would explain the presence of
SL1-spliced internal transcripts. This hypothesis has been
suggested previously [19]. However, it has also been proposed
that the degree of coupling between adjacent genes within an
operon may influence the relative levels of SL1- and SL2-
spliced message, so that a reduction in coupling efficiency to
SL2 may lead to SL1 splicing. In this regard, cgt-3 may be
informative. As described above, the first exon of cgt-3 is
located just 100 bp downstream of vps-35. The clones isolated
in this work containing this exon were trans-spliced to SL2.
Furthermore, of 14 ESTs currently reported that contain a
spliced leader sequence, only one (yk1437e11) is trans-spliced
to SL1 (Table 1). The cgt-3 isoform produced by the expression
of this exon is F59G1.1b.1 (Fig. 3). Clones obtained for the
variant that starts with the next exon downstream, F59G1.1b.2,
are trans-spliced with both SL1 and SL2, although ESTs are
very SL1 biased (Table 1). Finally, based on our data and ESTs,
the variant F59G1.1d.1 (beginning at the third exon) is trans-
spliced exclusively to SL1. These results may be explained by
different coupling efficiencies and by the presence of internal
promoters. The most upstream spliced variant begins with an
exon that is very close to vsp-35, which couples efficiently to
vps-35 processing and is thus predominantly spliced to SL2,
with only rare “aberrant” splicing SL1. The most downstream
variant is not coupled to vps-35 processing and is transcribed
from a promoter in the large upstream intron and is thus SL1
trans-spliced. The middle splice variant couples to vps-35
polyadenylation, thus resulting in some SL2 trans-splicing, but
its distance from vps-35 (approximately 1.3 kb) makes this
somewhat inefficient, leading to more SL1 splicing. Alterna-
tively, another promoter may lie upstream of this variant and
this may drive the SL1 trans-spliced mRNAs.
Fig. 4. GFP expression driven by autonomous regulatory sequences in transgenic worms carrying constructs F59G1.1::gfp, ptp-2::gfp, and vrk-1::gfp. (a–c)
Expression of F59G1.1::gfp in pharynx and gut (a), anal cells (b), and spermatheca (sph) (c). (d–f) ptp-2::gfp produced fluorescence in some head neurons (d), gut and
spermatheca (e), and body wall muscle (f). (g–h) vrk-1::gfp was expressed in several cells, which included head neurons (g) and phasmids (h).
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due to internal promoters and coupling, we performed an
experiment in which we could compare the endogenous trans-Fig. 5. Differential expression of frh-1 and F59G1.4. (a) Representative confocal ima
(b) Image of animals carrying the construct F59G1.4::gfp.splicing of frh-1 with the trans-splicing of this gene present in
chromosomal arrays. To accomplish this, we used worms
carrying the construct frh-1::gfp 2 (Figs. 2a and 6a). We carriedge of animals carrying the array composed of frh-1::gfp2 and the cosmid F59G1.
398 R.P. Vázquez-Manrique et al. / Genomics 89 (2007) 392–401out RT-PCR using SL1 or SL2 forward primers on RNA
obtained from these worms, followed by Southern blot analysis
of the products. To amplify endogenous transcripts from the
genes, we used a gene-specific reverse primer (Supplementary
Table S1), and to specifically amplify transcripts from the
transgenes, we used a primer in the gfp sequence. The results
show that endogenous expression of frh-1 is mostly SL2
spliced, presumably because expression is coupled to poly-
adenylation of the upstream gene (Fig. 6b). In contrast, the
expression of the extrachromosomal constructs, which is possi-
ble only through internal promoters, shows higher SL1 splicing
(Fig. 6b). These data suggest that internal promoters can be a
source of SL1-spliced mRNA for genes located downstream in
an operon that would otherwise be trans-spliced to SL2.
The CEOP2232 operon comprises a heterogeneous set of
genes, but its structure is highly conserved through the genus
Caenorhabditis
It has been demonstrated that, in some cases, the genes
located in C. elegans operons are implicated in the same
physiological pathway or function, as is common in prokaryoticFig. 6. Trans-splicing in endogenous and transgenic frh-1. (a) Genomic region
of frh-1 and the construct used to investigate the trans-splicing of this gene. The
reverse primers used are shown under each structure. gfpR2 is specific to gfp and
thus will only give products from expression of the transgene. Only the
endogenous expression of frh-1 can be coupled to the processing of cgt-3. This
will increase the contribution of SL2 trans-splicing. In contrast, expression from
the transgene can only result from internal promoters (white arrow upstream of
frh-1), thus producing SL1 trans-spliced mRNAs. (b) Southern blot showing the
products of RT-PCR for transgenic expression (the leftmost two lanes) or
endogenous expression (the rightmost two lanes) of frh-1, in the transgenic
animals. Expression from the transgenic array produces more SL1-spliced frh-1
product, whereas the autonomous expression of frh-1 is associated mostly with
SL2 [15].operons [26–28]. Blumenthal and Gleason demonstrated the
existence of several operons containing genes for proteins with
clearly related functions and discussed the possibility that these
genes are co-regulated to synchronize their expression [3].
Furthermore, this arrangement has made it possible to predict
the function of a human gene, based on the presence of a C.
elegans homologue in an operon containing a gene of known
function [29]. Hence, operons can be used as a tool to identify
partner proteins [30], something that would contribute to our
understanding of frataxin function. Although the function of
frataxin is not well understood, it is known to be mitochondrial
and a range of mitochondria-related roles have been suggested
for it, including the following: free radical detoxification, heme
biosynthesis, and energy conversion [15]. Thus, if any of the
proteins of CEOP2232 are related to frataxin in function, we
might expect that these proteins would also be mitochondrial or
would have functional properties related to proposed frataxin
functions. We surveyed the nature of the genes in the operon.
There are two genes, tsp-18 and F59G1.8, with no clear homo-
logues in other organisms. F59G1.8 has no known domains, so
its function cannot be predicted. tsp-18 is a member of the
tetraspanin superfamily, which regulates cell migration, fusion,
and signaling events [31]. Neither of these proteins is predicted
to be mitochondrial by the Mitoprot II program [32]. F59G1.4
has a very low level of similarity to a human protein of
unknown function, ARMC9 [33], but does have a predicted
probability of 73.3% that it is mitochondrial (using Mitoprot II).
The remaining proteins have clear homologues: vps-35 is an
orthologue of the yeast vacuolar protein sorting-associated
protein 35; cgt-3 is similar to ceramide glycosyltransferases
involved in the synthesis of membrane glycolipids; ptp-2 is a
nonreceptor tyrosine phosphatase involved in C. elegans
oogenesis [22]; and vrk-1 is a protein kinase that is essential
for C. elegans viability (www.wormbase.org). Therefore, the
CEOP2232 operon contains a heterogeneous set of genes, with
no clear pattern of related function.
Given the apparent heterogeneity of the genes in the operon,
we wondered to what extent this gene arrangement is conserved.
We surveyed the structure of the operon in the genus Caenor-
habditis, by comparing CEOP2232 to the C. briggsae and C.
remanei genomes. Six of the eight genes (F59G1.4, vps-35,
cgt-3, frh-1, ptp-2, and vrk-1) are highly conserved and are
located in the same order and separated by similar distances in
both of these species (data not shown). tsp-18 is also present in
a similar position, but is more diverged (Supplementary Fig.
S2a). The F59G1.8 sequence also shows some degree of
similarity between C. elegans, C. briggsae, and C. remanei
(Supplementary Fig. S2b) and is also located in a similar
position. Hence, the structure of the operon is conserved among
the three species. The location of the C. elegans frataxin gene
within a large operon made up of such a heterogeneous set of
genes raises questions about the function of this organization.
One possibility is that, although these genes do not show any
apparent link to frataxin function, they may nevertheless be
directly or indirectly involved in the regulation of frataxin
production or function. Alternatively, the genes may not be
functionally related, but may instead share common regulatory
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proposed that small genomes, such as that of C. elegans,
can favor compaction of genes and hence the emergence of
operons, as genes evolve to share promoters and other
regulatory sequences [3]. However, the complex nature of the
regulatory elements in COP2232 make a simple model of such
co-regulation problematic in this case.
CEOP2232 shows differential selective pressure along its
structure: tsp-18 and F59G1.8
Despite the high degree of conservation of the structure of
the CEOP2232 operon within the genus Caenorhabditis and of
many of the genes in the operon, tsp-18 and F59G1.8 are not
highly conserved in sequence. In addition, they both appear to
be expressed at low levels. cDNAs of tsp-18 were difficult to
detect and there are no ESTs for this gene (www.wormbase.org
release WS157). We isolated one cDNA, which did not contain
the first two predicted exons (www.wormbase.org). F59G1.8
also appears to be present at low levels. We consistently
obtained very low yields in PCR assays using several different
sets of primers along the predicted gene and, again, there are no
ESTs for F59G1.8 (www.wormbase.org release WS157). We
obtained a single cDNA clone of F59G1.8 with an unpredicted
exon between predicted exons 3 and 4. However, exon 4 was
23 bp longer than predicted, leading to an mRNA in which the
reading frame in the next to last exon is disrupted. This clone
may be the result of an aberrant splicing event, but another
possible explanation is that F59G1.8 is a pseudogene. In
addition to apparently very low levels of expression, F59G1.8
shares very little sequence similarity with the closely related
species C. briggsae and C. remanei [34] (Supplementary Fig.
S2), suggesting that this gene has not been subject to selective
pressure. If F59G1.8 is a nonfunctional gene, why is it present
within the operon? It might be argued that it is required to
maintain the functional architecture of the operon and thus
correct expression of downstream genes.
Conclusions
In this work, we describe the structure and regulation of the
expression of the frataxin-encoding operon, CEOP2232. We
provide data supporting the presence of internal and autono-
mous promoters within the operon. This hypothesis has been
suggested previously [19]. It has also been proposed that dif-
ferential expression levels of genes expressed from the same
promoter may be achieved by posttranscriptional regulation
[11]. However, this cannot explain all of our results, as some of
the constructs discussed in this work do not contain the coding
sequence of the gene of interest, but only gfp fused to their first
codons (cgt-3::gfp and frh-1::gfp3). The internal promoters in
CEOP2232 may serve to produce differential expression of
genes through transcriptional regulation. We show that internal
promoters may be a source of SL1-mediated trans-splicing, as
suggested previously [19]; however, it also seems likely that
some of the SL1 splicing, especially that observed in predo-
minantly SL2-spliced mRNAs, results from poor couplingrather than transcription from internal promoters. Our results
show that there are at least two groups of co-regulated genes.
The first block includes the genes in the 5′ region of the operon,
from F59G1.4 to vps-35, and possibly the F59G1.1b.1 form of
cgt-3. Their expression is driven by a promoter located up-
stream of the whole operon, resulting in a similar neuronal
pattern of expression. The second group may contain the genes
downstream of vps-35, expressed from a promoter located in
the interexon regions at the 5′ end of cgt-3, which produces
expression in tissues other than neurons, such as gut, sperma-
theca, and pharynx. This region regulates, at least, cgt-3 and
frh-1. It is possible that a third block of expression exists, as
ptp-2 and vrk-1 seem to have autonomous promoters as well.
Why is there such a striking difference in the expression of the
F59G1.4-associated group from that of the frataxin-associated
group? It is tempting to argue that these two groups of genes are
the remains of two ancient operons that became combined in the
same polycistronic unit through cgt-3, which links the expres-
sion of vsp-35 to that of the downstream genes. Thus, the pre-
sence of internal promoters within the CEOP2232 operon may
be a vestige of the autonomy of the downstream genes, now
integrated in a polycistronic structure. Blumenthal and co-
workers have discussed the possibility that polycistrons may be
stable structures because downstream genes in an operon lose
their autonomy, since their expression depends on the promoters
of upstream genes [3,11]. In the case of CEOP2232, selective
pressure may also preserve internal regulatory sequences, as the
expression of its constituent genes is different. Analysis of these
genes in more distantly related species may shed further light on
these evolutionary questions.
Finally, is CEOP2232 a peculiarity in the C. elegans genome
or are there more examples of such complex operons? The
existence of internal promoters providing a finer regulation of
some genes of the ABC transporter family has been suggested
[20]. Another example of a potential internal promoter within an
operon has been shown by Xue and co-workers [35], who
described the expression of mtm-6, the last gene contained in
the 5-gene operon CEOP3784. A construct containing 3.3 kb of
genomic DNA directly upstream of the first exon of mtm-6
drives gfp in the intestine [35] (Supplementary Fig. S3). This
genomic fragment does not contain the whole 5′ region of the
operon, so that this expression is not driven by a promoter
upstream of the first gene of the polycistronic unit. Like cgt-3,
mtm-6 has a complex structure in its 5′ region that produces
alternative splicing (Supplementary Fig. S3). We produced an
additional mtm-6 construct, using the genomic region contain-
ing the 5′ region of the gene, including a large intron (4 kb) that
we suspected could contain another internal promoter. This
construct showed neuronal expression (Supplementary Fig. S3),
which is in contrast with the intestinal expression described
previously for mtm-6 [35]. Hence, CEOP3487 also contains
internal promoters that regulate mtm-6 in a complex manner.
We propose that common regulatory sequences within operons
such as CEOP2232 and CEOP3784 may provide coordinated
regulation of constituent genes, but additional control through
internal promoters provides further fine regulation, and that this
characteristic may be found in other C. elegans operons.
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Strains and worm culture
Worms were cultured using standard techniques and media [36,37]. We used
the wildtype strain Bristol (N2), supplied by the Caenorhabditis Genetics
Centre (University of Minnesota, MN), for all experiments. All strains were
maintained at 20°C.
Reverse transcription and PCR
Worms were grown on standard NGM plates. RNAwas isolated from these
worms using an RNeasy kit (Qiagen), following the manufacturer’s method for
animal tissues. To remove DNA, RNA was treated with DNase I (Roche) for
20 min at 37°C followed by inactivation at 75°C for 20 min. For cDNA
synthesis, 5 μg of total RNAwas reverse-transcribed using random hexamers as
primers and 4 U of MMLV reverse transcriptase (Invitrogen). Subsequent PCRs
were performed using HiFi DNA Polymerase (Roche), according to the
manufacturer’s instructions.
Southern blot analysis
We prepared total RNA from the strains carrying the construct frh-1::gfp2
and performed RT-PCR as described above, using the primers described under
Results. The products of these reactions were separated on a 0.8% agarose gel
and then transferred to a nylon membrane (Roche), using a standard procedure
[38]. The filters were probed with the entire F59G1 cosmid labeled with
digoxigenin using random primers, following the procedure recommended by
the manufacturer (Roche). Hybridization was carried out overnight at 65°C and
the membrane was washed at high stringency: 0.1× SSC, 0.1% SDS at 65°C
(where 1× SSC is 15 M NaCl and 0.015 M sodium citrate). Detection was
performed using an alkaline phosphatase anti-digoxigenin antibody and CSPD
Star as the enzyme substrate (Roche) and visualized using X-ray film.
Gene cloning and sequencing
To identify the ends of each gene, we first tested for trans-splicing to SL1 and
SL2 using a gene-specific oligonucleotide as the reverse primer (Supplementary
Table S1). The 3′ ends were determined using 3′-RACE, carried out as described
previously [39]. Products were cloned into pGEM-T (Promega) and then
sequenced. Having established each end, we used this information to amplify
full-length cDNAs. These products were cloned and sequenced, as described
above, to obtain the whole structure of each gene. All transcripts were easily
amplified, apart from those corresponding to tsp-18 and F59G1.8, which were
all present at low levels and were detected by Southern blot. The sequences
obtained were deposited with the GenBank Data Library under the follow-
ing accession numbers: F59G1.4, DQ178637; tsp-18(F59G1.2), DQ178635;
F59G1.8, DQ178638; vps-35(F59G1.3), DQ178636; cgt-3, DQ178632-
DQ178634 (F59G1.1) ; frh-1(F59G1.7), AY048153 [16]. The sequences
obtained for ptp-2(F59G1.5) and vrk-1(F28B12.3) matched those of the
F59G1.5.1 and F28F12.3.2 predicted models (www.wormbase.org, ws157).
Generation of gfp fusions
To investigate the expression pattern of genes, we produced PCR products in
which gfp was fused to the genomic region to be investigated and in-frame with
the gene of interest. The fusion of genomic and gfp sequences was achieved by
PCR fusion [40]. Briefly, we generated two PCR products: in PCR 1, we
amplified the gene of interest with appropriate upstream genomic sequences (see
Supplementary Table S1 for the primers used), and in PCR 2, the gfp coding
sequence plus the 3′-UTR from unc-54 gene were amplified from pPD95.75
(http://www.ciwemb.edu/). The 3′ primer used in PCR 1 had a 24-nt overhang
that matched gfp in pPD95.75. Fusion transgenes were then obtained by nested
PCR using as template a mixture of the products from PCRs 1 and 2 at 20–
50 ng/μl each (Supplementary Table S1). For this reaction, nested primers
downstream of the 5′ primer in PCR 1, specific for each gene, and a specific
primer for the gfp cassette were used.Production of transgenic animals and microscopic observation
The transgenic strains were generated by microinjection [41]. We injected
the gfp fusion constructs at a concentration of 20–50 ng/μl into wildtype worms.
We used the dominant marker rol-6(su1006) (plasmid pRF4) [42] at a
concentration of 100 ng/μl, to select transgenic animals. We examined at least
two independent transgenic lines for every construct injected. Images were
obtained from worms anesthetized in 1 mM levamisole using a Leica SP laser
scanning confocal microscope (Leica Microsystems).
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